SEC Filing Summary: AspenBio Pharma, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by AspenBio Pharma, Inc. on August 23, 2007. The registrant is incorporated in Colorado and maintains its principal executive offices in Castle Rock, CO. The filing serves to disclose a significant corporate event regarding the listing of the company's securities.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on a regulatory disclosure event rather than financial performance results.
Material Changes
The primary material event disclosed is the announcement that AspenBio Pharma, Inc. will list its shares on the Nasdaq Capital Markets Exchange under the stock symbol "APPY". This information was disseminated via a press release issued on August 23, 2007, which is attached as Exhibit 99.1.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, financial outlook, specific risks, or contingencies beyond the standard disclosure of the Nasdaq listing. No unusual items or financial restatements are mentioned in this document.
Investor Verification Checklist
- Verify the official listing date and trading commencement on the Nasdaq Capital Markets under symbol "APPY".
- Review the full text of the press release (Exhibit 99.1) for details on the listing process and any associated conditions.
- Confirm the company's current financial status through its most recent 10-K or 10-Q filings, as this 8-K contains no financial data.
- Check for any subsequent filings regarding the status of the Nasdaq listing.